Home LiteratureArticle Details
PMID: 12960121 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.

Tajiri T, Liu X, Thompson PM, Tanaka S, Suita S, Zhao H, Maris JM, Prendergast GC, Hogarty MD

Abstract

Amplification of the MYCN proto-oncogene is strongly correlated with poor outcome in neuroblastoma (NB), although deregulated MYCN is a potent inducer of apoptosis. BIN1 (2q14) encodes multiple isoforms of a Myc-interacting adaptor protein that has features of a tumor suppressor, including the ability to inhibit Myc-mediated cell transformation and to promote apoptosis. We hypothesized that BIN1 may function as a suppressor gene in NB, because Bin1 is highly expressed in neural tissues and binds the Myc Box motifs that are conserved in MycN. EXPERMENTAL DESIGN: Expression of MYCN, total BIN1, and BIN1 isoforms were determined in 56 primary NBs using the real-time PCR. Expression was correlated with biological and genetic features. To determine the functional significance of BIN1 expression we ectopically expressed BIN1 isoforms in NB cell lines with and without MYCN amplification, and assessed clonogenic growth. Four predominant BIN1 isoforms resulting from alternative splicing of exon 12A (a neural tissue-specific exon) and exon 13 (a Myc-binding domain encoding exon) were variably expressed in the 56 primary NBs. Expression of BIN1 was lower in: NBs with MYCN amplification (n = 10) compared with those without, P < 0.03; in International Neuroblastoma Risk Group high-risk NB (n = 19) compared with low- or intermediate-risk NB, P < 0.01; and in metastatic NB (n = 21) compared with localized NB, P < 0.06. BIN1 inactivation by deletion or genomic rearrangement was identified infrequently. Forced expression of BIN1 isoforms containing the Myc-binding domain (with or without exon 12A) inhibited colony formation in NB cell lines with MYCN amplification (P < 0.01) but not in those without. Forced expression of BIN1 isoforms with a MBD deletion did not inhibit colony formation in any cell line assessed. These data support that reduced BIN1 expression contributes to the malignant phenotype of childhood NB. As we reported previously, BIN1 may function to circumvent MycN-mediated apoptosis in NBs with MYCN amplification.

MeSH Terms
Adaptor Proteins, Signal Transducing Age Factors Algorithms Amino Acid Motifs Brain/metabolism Carrier Proteins/chemistry Cell Line, Tumor Colony-Forming Units Assay DNA Mutational Analysis Exons Gene Expression Regulation, Neoplastic Humans Infant Infant, Newborn N-Myc Proto-Oncogene Protein Neuroblastoma/metabolism,pathology Nuclear Proteins/chemistry,metabolism Oncogene Proteins/metabolism Peptides/chemistry Plasmids/metabolism Protein Isoforms Protein Structure, Tertiary Proto-Oncogene Mas Reverse Transcriptase Polymerase Chain Reaction Tumor Suppressor Proteins/chemistry
Chemicals
Adaptor Proteins, Signal Transducing BIN1 protein, human Carrier Proteins MAS1 protein, human MYCN protein, human N-Myc Proto-Oncogene Protein Nuclear Proteins Oncogene Proteins Peptides Protein Isoforms Proto-Oncogene Mas Tumor Suppressor Proteins
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Tajiri Tatsuro
Department of Pediatric Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Liu Xueyuan
Thompson Patricia M
Tanaka Shinji
Suita Sachiyo
Zhao Huaqing
Maris John M
Prendergast George C
Hogarty Michael D
Article Info
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Abbr.
Clin Cancer Res
ISSN
1078-0432
Published
2003-08-15
Pages
3345-55
Language
English
Region
United States
NLM ID
9502500
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com